期刊文献+

HPLC法测定炔雌醇透皮贴剂中药物含量和有关物质 被引量:4

HPLC determination of the content of ethinyl estradiol and related substances in patch
下载PDF
导出
摘要 目的:建立 HPLC 测定炔雌醇透皮贴剂中药物含量和有关物质的方法。方法:色谱柱为 Symmetry Shield RP 18(3.9 mm×150 mm,5 μm),乙睛-水(45:55)为流动相,流速为1.0 mL·min^(-1),检测波长为220 nm。结果:此方法的线性范围为4.27~68.29μg·mL^(-1)(r=0.9999),平均回收率(n=9)为99.7%。炔雌醇及其有关物质峰之间能完全分离。结论:该方法灵敏准确,可作为炔雌醇透皮贴剂中药物含量和有关物质的测定方法。 Objective: To establish an HPLC method for determination of the content of ethinyl estradiol and related substances in patch. Method: HPLC with Symmetry Shield RP 18 (3.9 mm × 150 mm ,5 μm) , acetonitrile and water(45 : 55 ) as mobile phase, flow rate : 1.0 mL · min ^- 1 , UV detector at 220 nm. Results : The linear range of ethinyl estradiol was 4.27 - 68.29 μg · mL^-1 ( r = 0. 9999 ). The average recovery( n = 9 ) was 99.7%. Ethinyl estradiol and related substances could be separated by this method. Conclusion: The method is sensitive and accurate, it can be used as a method for the determination of content of ethinyl estradiol and related substances in patch.
出处 《药物分析杂志》 CAS CSCD 北大核心 2008年第5期776-778,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 透皮贴剂 炔雌醇 HPLC 有关物质 transdermal delivery patch ethinyl estradiol HPLC related substances
  • 相关文献

参考文献6

  • 1CHEN Xin-qian(陈新谦),JIN You-yu(金有豫),TANG Guang(汤光).New Edition of Medica(新编药物学).15th Ed(第十五版).Beijing(北京):People’s Medical Publishing House(人民卫生出版社),2003.581
  • 2邵敬於.雌激素在妇科的合理选用[J].中国新药与临床杂志,2004,23(12):897-900. 被引量:15
  • 3Chp(中国药典).2005.VolⅡ(二部):Appendix(附录)ⅦP
  • 4LUXiang-lin(吕湘林) WANGXiu-yun(汪秀云) CAOXiu-ling(曹秀玲).Analytical studies on compound preparations containing ethinylestradiol(含炔雌醇复方避孕制剂的分析)[J].药学学报,1986,21(7):532-532.
  • 5USP 29 - NF 24. 2006. 863
  • 6Prasad SD, Reddy GC, Prasad PSS,et al, Simultaneous HPLC estimation of levonorgestrel and ethinylestradiol from tablets. Indian J Pharm Sci,2004,66(2) :231

二级参考文献1

  • 1ROSSOUW JE, ANDERSON GL, PRENTICE RL, et al. Risks and benifits of estrogen plus progrstin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled tria[J]. JAMA,2002,288(3):321-333.

共引文献47

同被引文献1980

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部